What Can You Expect at the Measuring Impact in Medical Affairs Summit

The Measuring Impact in Medical Affairs Summit is your opportunity to explore how teams are demonstrating their value as Medical Affairs rapidly evolves into a strategic, impact-driven function. This one-of-a-kind meeting brings together leaders from pharma and biotech to share practical, proven approaches for building meaningful KPIs, adopting AI-enabled tools, and clearly demonstrating the real-world value of Medical Affairs activities.

Across interactive workshops, expert-led sessions, and in-depth case studies, you’ll uncover how high-performing teams:

  • Capture high-quality, decision-shaping insights 
  • Communicate impact effectively to senior leadership 
  • Strengthen cross-functional alignment to deliver measurable outcomes 

From Field Medical and Medical Communications to Evidence Generation and beyond, the summit highlights how every Medical Affairs subfunction can contribute to a unified, outcomes-focused strategy.

Join 50+ senior Medical Affairs professionals from organizations including Regeneron, Boehringer Ingelheim, Abbvie, Alexion, and Travere. Connect with peers, exchange best practices, and walk away with actionable frameworks you can put to work immediately.

Leave equipped to translate data, insights, and scientific engagement into demonstrable impact, and help shape the next generation of Medical Affairs excellence.

Download the Agenda
Measuring Impact in Medical Affairs Summit Audience

Unmissable Event Highlights

From Insight to Outcome: Building a Measurement Framework that Demonstrates True Medical Affairs Impact

Regeneron’s Carl de Luca explores how to move beyond activity‑based metrics to generate high‑quality insights that identify meaningful clinical and educational gaps capable of shaping robust medical strategy.

The Future of Medical Affairs, Evolving from a Support Function to a Strategic Driver of Business & Patient Impact

Merz Therapeutics’ Selena Freisens explores how Medical Affairs is evolving into a data‑led strategic pillar - shaping clinical decisions, commercial impact, and patient outcomes within an increasingly complex healthcare landscape

Bridging the Gap and Turning Scientific Insights into Strategic Action

AbbVie’s Denise Briggs reveals how Medical Affairs teams can systematically capture and share insights across R&D and commercial functions — proving their strategic value through aligned objectives and measurable outcomes.

Explore The Full Event Guide

  • 50+ Attendees
  • 16+ World-Class Speakers
  • 2 Hands-on Workshops
  • Unrivalled Networking Opportunities
  • Multi-Therapy Medical Affairs Perspectives
Measuring Impact in Medical Affairs - Brochure Image

Attending Companies Include

Abbvie
Alexion Pharmaceuticals
Bayer
Boehringer Ingelheim
Cadrenal Therapeutics
Genentech
Merz Therapeutics
Regeneron
Sanofi
Taysha Gene Therapies
Travere Therapeutics
Measuring Impact in Medical Affairs Summit Presenting
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

Measuring Impact in Medical Affairs Summit Partnering
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Measuring Impact in Medical Affairs Summit Networking
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.